{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:04:20Z","timestamp":1791651860543,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A0303131003"],"award-info":[{"award-number":["2018A0303131003"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program of Guangzhou","award":["201707010449"],"award-info":[{"award-number":["201707010449"]}]},{"name":"Toka-Donghua Educational and Cultural Exchange Foundation"},{"name":"Setsuro Fujii Memorial of Medical Sciences and The Osaka Foundation for Promotion of Fundamental Medical Research"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health, Labour and Welfare and Ministry of Education, Culture, Sports, Science and Technology","award":["20K17953"],"award-info":[{"award-number":["20K17953"]}]},{"name":"Ministry of Health, Labour and Welfare and Ministry of Education, Culture, Sports, Science and Technology","award":["17K16626"],"award-info":[{"award-number":["17K16626"]}]},{"name":"Ministry of Health, Labour and Welfare of Japan","award":["Grant-in-Aid for Cancer Research"],"award-info":[{"award-number":["Grant-in-Aid for Cancer Research"]}]},{"name":"Ministry of Health, Labour and Welfare of Japan","award":["17K19810"],"award-info":[{"award-number":["17K19810"]}]},{"name":"Ministry of Health, Labour and Welfare of Japan","award":["19K09451"],"award-info":[{"award-number":["19K09451"]}]},{"name":"National Cancer Center Research and Development Fund"},{"name":"Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ischemic stroke, including transient ischemic attack (TIA) and acute-phase cerebral infarction (aCI), is a serious health problem in the aging society. Thus, this study aimed to identify TIA and aCI biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In 19 patients with TIA, candidate antigens recognized by serum IgG autoantibodies were screened using a human aortic endothelial cell cDNA library. Through amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA), serum antibody levels against the candidate antigens were examined in healthy donor (HD), TIA, and aCI cohorts (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009285, 92, and 529). The plasma antibody levels in the Japan Public Health Center-based Prospective Cohort Study (1991\u20131993) were also examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The candidate antigens were aldolase A (ALDOA) and fumarate hydratase (FH). In AlphaLISA, patients with TIA or aCI had higher anti-ALDOA antibody (ALDOA-Ab) and anti-FH antibody (FH-Ab) levels than the HDs (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). In a multivariate logistic regression analysis, the ALDOA-Ab (odds ratio [OR]: 2.46,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0050) and FH-Ab (OR: 2.49,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0037) levels were independent predictors of TIA. According to the case\u2013control study, the ALDOA-Ab (OR: 2.50,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and FH-Ab (OR: 2.60,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) levels were associated with aCI risk. In a correlation analysis, both ALDOA-Abs and FH-Abs were well associated with hypertension, coronary heart disease, and habitual smoking. These antibody levels also correlated well with maximum intima\u2013media thickness, which reflects atherosclerotic stenosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ALDOA-Abs and FH-Abs can be novel potential biomarkers for predicting atherosclerotic TIA and aCI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02301-w","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:03:31Z","timestamp":1625789011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction"],"prefix":"10.1186","volume":"21","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Matsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Iwadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Iso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Tsugane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kamitsukasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Aotsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kashiwado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Tomiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Shinmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anding","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-3881","authenticated-orcid":false,"given":"Takaki","family":"Hiwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"issue":"6","key":"2301_CR1","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276\u201393. https:\/\/doi.org\/10.1161\/STROKEAHA.108.192218.","journal-title":"Stroke"},{"issue":"7","key":"2301_CR2","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors J, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(7):2064\u201389. https:\/\/doi.org\/10.1161\/STR.0b013e318296aeca.","journal-title":"Stroke"},{"issue":"8","key":"2301_CR3","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/01.STR.0000134416.89389.9d","volume":"35","author":"LD Lisabeth","year":"2004","unstructured":"Lisabeth LD, Ireland JK, Risser JM, Brown DL, Smith MA, Garcia NM, Morgenstern LB. Stroke risk after transient ischemic attack in a population-based setting. Stroke. 2004;35(8):1842\u20136. https:\/\/doi.org\/10.1161\/01.STR.0000134416.89389.9d.","journal-title":"Stroke"},{"issue":"4","key":"2301_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/01.STR.0000158917.59233.b7","volume":"36","author":"D Kleindorfer","year":"2005","unstructured":"Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, Woo D, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005;36(4):720\u20133. https:\/\/doi.org\/10.1161\/01.STR.0000158917.59233.b7.","journal-title":"Stroke"},{"issue":"7","key":"2301_CR5","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(7):2160\u2013236. https:\/\/doi.org\/10.1161\/STR.0000000000000024.","journal-title":"Stroke"},{"issue":"10","key":"2301_CR6","doi-asserted-by":"publisher","first-page":"e1011","DOI":"10.1097\/CCM.0000000000002549","volume":"45","author":"RH Bonow","year":"2017","unstructured":"Bonow RH, Witt CE, Mosher BP, Mossa-Basha M, Vavilala MS, Rivara FP, et al. Transcranial Doppler microemboli monitoring for stroke risk stratification in blunt cerebrovascular injury. Crit Care Med. 2017;45(10):e1011\u20137. https:\/\/doi.org\/10.1097\/CCM.0000000000002549.","journal-title":"Crit Care Med"},{"issue":"4","key":"2301_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1161\/STROKEAHA.111.637421","volume":"43","author":"SB Coutts","year":"2012","unstructured":"Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD, et al. CT\/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke. 2012;43(4):1013\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.111.637421.","journal-title":"Stroke"},{"issue":"1","key":"2301_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2214\/ajr.159.1.1609697","volume":"159","author":"S Wolpert","year":"1992","unstructured":"Wolpert S, Caplan LR. Current role of cerebral angiography in the diagnosis of cerebrovascular diseases. AJR Am J Roentgenol. 1992;159(1):191\u20137. https:\/\/doi.org\/10.2214\/ajr.159.1.1609697.","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"2301_CR9","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1073\/pnas.92.9.3893","volume":"92","author":"S Stemme","year":"1995","unstructured":"Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 1995;92(9):3893\u20137. https:\/\/doi.org\/10.1073\/pnas.92.9.3893.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"2301_CR10","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015\u201322. https:\/\/doi.org\/10.1001\/jama.288.16.2015.","journal-title":"JAMA"},{"issue":"2","key":"2301_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/STROKEAHA.107.513259","volume":"40","author":"V Nambi","year":"2009","unstructured":"Nambi V, Hoogeveen RC, Chambless L, Hu Y, Bang H, Coresh J, et al. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the atherosclerosis risk in communities (ARIC) study. Stroke. 2009;40(2):376\u201381. https:\/\/doi.org\/10.1161\/STROKEAHA.107.513259.","journal-title":"Stroke"},{"issue":"11","key":"2301_CR12","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1161\/01.str.31.11.2648","volume":"31","author":"J Kramer","year":"2000","unstructured":"Kramer J, Harcos P, Proh\u00e1szka Z, Horv\u00e1th L, Kar\u00e1di I, Singh M, et al. Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases. Stroke. 2000;31(11):2648\u201352. https:\/\/doi.org\/10.1161\/01.str.31.11.2648.","journal-title":"Stroke"},{"issue":"9735","key":"2301_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O'Donnell","year":"2010","unstructured":"O\u2019Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(10)60834-3.","journal-title":"Lancet"},{"key":"2301_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12883-015-0388-z","volume":"15","author":"LS Dolmans","year":"2015","unstructured":"Dolmans LS, Rutten FH, El Bartelink ML, Seppenwoolde G, van Delft S, Kappelle LJ, Hoes AW. Serum biomarkers for the early diagnosis of TIA: The MIND-TIA study protocol. BMC Neurol. 2015;15:119. https:\/\/doi.org\/10.1186\/s12883-015-0388-z.","journal-title":"BMC Neurol"},{"issue":"22","key":"2301_CR15","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJM199412013312202","volume":"331","author":"P Amarenco","year":"1994","unstructured":"Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. New Engl J Med. 1994;331(22):1474\u20139. https:\/\/doi.org\/10.1056\/NEJM199412013312202.","journal-title":"New Engl J Med"},{"key":"2301_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1741-7015-12-47","volume":"12","author":"E Matsuura","year":"2014","unstructured":"Matsuura E, Atzeni F, Sarzi-Puttini P, Turiel M, Lopez LR, Nurmohamed MT. Is atherosclerosis an autoimmune disease? BMC Med. 2014;12:47. https:\/\/doi.org\/10.1186\/1741-7015-12-47.","journal-title":"BMC Med"},{"issue":"1","key":"2301_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11926-009-0009-1","volume":"11","author":"E Matsuura","year":"2009","unstructured":"Matsuura E, Kobayashi K, Lopez LR. Atherosclerosis in autoimmune diseases. Curr Rheumatol Rep. 2009;11(1):61\u20139. https:\/\/doi.org\/10.1007\/s11926-009-0009-1.","journal-title":"Curr Rheumatol Rep"},{"key":"2301_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5772\/63218","volume":"5","author":"T Hiwasa","year":"2016","unstructured":"Hiwasa T, Zhang XM, Kimura R, Ohno M, Chen PM, Nishi E, et al. Elevated adiponectin antibody levels in serum of patients with atherosclerosis-related coronary artery disease, cerebral infarction and diabetes mellitus. J Circ Biomark. 2016;5:8. https:\/\/doi.org\/10.5772\/63218.","journal-title":"J Circ Biomark"},{"issue":"25","key":"2301_CR19","doi-asserted-by":"publisher","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","volume":"92","author":"U Sahin","year":"1995","unstructured":"Sahin U, T\u00fcreci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA. 1995;92(25):11810\u20133. https:\/\/doi.org\/10.1073\/pnas.92.25.11810.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2301_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1385\/1-59259-862-5:137","volume":"109","author":"O T\u00fcreci","year":"2005","unstructured":"T\u00fcreci O, Usener D, Schneider S, Sahin U. Identification of tumor-associated autoantigens with SEREX. Methods Mol Med. 2005;109:137\u201354. https:\/\/doi.org\/10.1385\/1-59259-862-5:137.","journal-title":"Methods Mol Med"},{"key":"2301_CR21","doi-asserted-by":"publisher","first-page":"Unit 20.7","DOI":"10.1002\/0471142735.im2007s65","volume":"Chapter 20","author":"MJ Scanlan","year":"2005","unstructured":"Scanlan MJ. Identification of human tumor antigens by serological analysis of recombinant cDNA expression libraries (SEREX). Curr Protoc Immunol. 2005;Chapter 20:Unit 20.7. https:\/\/doi.org\/10.1002\/0471142735.im2007s65.","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"2301_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0006-291x(02)00637-x","volume":"295","author":"Y Lim","year":"2002","unstructured":"Lim Y, Lee DY, Lee S, Park SY, Kim J, Cho B, et al. Identification of autoantibodies associated with systemic lupus erythematosus. Biochem Biophys Res Commun. 2002;295(1):119\u201324. https:\/\/doi.org\/10.1016\/s0006-291x(02)00637-x.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2301_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1348-0421.2004.tb03472.x","volume":"48","author":"M Kaneko","year":"2004","unstructured":"Kaneko M, Ono T, Matsubara T, Yamamoto Y, Ikeda H, Yoshiki T, et al. Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning. Microbio Immunol. 2004;48(9):703\u201311. https:\/\/doi.org\/10.1111\/j.1348-0421.2004.tb03472.x.","journal-title":"Microbio Immunol"},{"issue":"5","key":"2301_CR24","doi-asserted-by":"publisher","first-page":"R1133","DOI":"10.1186\/ar1798","volume":"7","author":"Y Lu","year":"2005","unstructured":"Lu Y, Ye P, Chen SL, Tan EM, Chan EK. Identification of kinectin as a novel Beh\u00e7et\u2019s disease autoantigen. Arthritis Res Ther. 2005;7(5):R1133\u20139. https:\/\/doi.org\/10.1186\/ar1798.","journal-title":"Arthritis Res Ther"},{"key":"2301_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jneuroim.2015.05.005","volume":"284","author":"M Muto","year":"2015","unstructured":"Muto M, Mori M, Hiwasa T, Takiguchi M, Iwadate Y, Uzawa A, et al. Novel serum autoantibodies against talin1 in multiple sclerosis: possible pathogenetic roles of the antibodies. J Neuroimmunol. 2015;284:30\u20136. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.05.005.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2301_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12967-015-0393-4","volume":"13","author":"T Machida","year":"2015","unstructured":"Machida T, Kubota M, Kobayashi E, Iwadate Y, Saeki N, Yamaura A, et al. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX). J Transl Med. 2015;13(1):71. https:\/\/doi.org\/10.1186\/s12967-015-0393-4.","journal-title":"J Transl Med"},{"issue":"5","key":"2301_CR27","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.18632\/oncotarget.23789","volume":"9","author":"H Wang","year":"2017","unstructured":"Wang H, Zhang XM, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, et al. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. Oncotarget. 2017;9(5):5600\u201313. https:\/\/doi.org\/10.18632\/oncotarget.23789.","journal-title":"Oncotarget"},{"issue":"2","key":"2301_CR28","doi-asserted-by":"publisher","first-page":"097","DOI":"10.4172\/17457580.1000097","volume":"11","author":"T Hiwasa","year":"2015","unstructured":"Hiwasa T, Machida T, Zhang XM, Kimura R, Wang H, Iwase K, et al. Elevated levels of autoantibodies against ATP2B4 and BMP-1 in sera of patients with atherosclerosis-related diseases. Immunome Res. 2015;11(2):097. https:\/\/doi.org\/10.4172\/17457580.1000097.","journal-title":"Immunome Res"},{"issue":"2","key":"2301_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18314\/gjbs.v1i2.27","volume":"1","author":"T Hiwasa","year":"2015","unstructured":"Hiwasa T, Zhang XM, Kimura R, Machida T, Kitamura K, Yamazoe R, et al. Association of serum antibody levels against TUBB2C with diabetes and cerebral infarction. Gratis J Biomed Sci. 2015;1(2):49\u201363. https:\/\/doi.org\/10.18314\/gjbs.v1i2.27.","journal-title":"Gratis J Biomed Sci"},{"key":"2301_CR30","doi-asserted-by":"publisher","unstructured":"Hiwasa T, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kunimatsu M, et al. Serum SH3BP5-specific antibody level is a biomarker of atherosclerosis. Immunome Res. 2017;13(2):132. https:\/\/doi.org\/10.4172\/1745-7580.1000132.","DOI":"10.4172\/1745-7580.1000132"},{"issue":"14","key":"2301_CR31","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","volume":"108","author":"M Naghavi","year":"2003","unstructured":"Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108(14):1664\u201372. https:\/\/doi.org\/10.1161\/01.CIR.0000087480.94275.97.","journal-title":"Circulation"},{"issue":"1","key":"2301_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35\u201341. https:\/\/doi.org\/10.1161\/01.str.24.1.35.","journal-title":"Stroke"},{"issue":"8","key":"2301_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04661","volume":"6","author":"Y Yoshida","year":"2020","unstructured":"Yoshida Y, Zhang XM, Wang H, Machida T, Mine S, Kobayashi E, et al. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases. Heliyon. 2020;6(8): e04661. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04661.","journal-title":"Heliyon"},{"issue":"5","key":"2301_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4172\/2155-9929.1000361","volume":"8","author":"XM Zhang","year":"2017","unstructured":"Zhang XM, Wang H, Mine S, Takemoto M, Yokote K, Kitamura K, et al. Association of serum anti-prolylcarboxypeptidase antibody marker with atherosclerotic diseases accompanied by hypertension. J Mol Biomark Diagn. 2017;8(5):361. https:\/\/doi.org\/10.4172\/2155-9929.1000361.","journal-title":"J Mol Biomark Diagn"},{"issue":"6","key":"2301_CR35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/ijc.20517","volume":"112","author":"K Nakashima","year":"2004","unstructured":"Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer. 2004;112(6):1029\u201335. https:\/\/doi.org\/10.1002\/ijc.20517.","journal-title":"Int J Cancer"},{"issue":"1","key":"2301_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1471-2407-14-452","volume":"14","author":"M Adachi-Hayama","year":"2014","unstructured":"Adachi-Hayama M, Adachi A, Shinozaki N, Matsutani T, Hiwasa T, Takiguchi M, et al. Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas. BMC Cancer. 2014;14(1):452. https:\/\/doi.org\/10.1186\/1471-2407-14-452.","journal-title":"BMC Cancer"},{"issue":"9","key":"2301_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jjco\/hyu096","volume":"44","author":"S Tsugane","year":"2014","unstructured":"Tsugane S, Sawada N. The JPHC study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol. 2014;44(9):777\u201382. https:\/\/doi.org\/10.1093\/jjco\/hyu096.","journal-title":"Jpn J Clin Oncol"},{"issue":"16","key":"2301_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/eurheartj\/eht043","volume":"34","author":"K Yamagishi","year":"2013","unstructured":"Yamagishi K, Iso H, Kokubo Y, Saito I, Yatsuya H, Ishihara J, et al. Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study. Eur Heart J. 2013;34(16):1225\u201332. https:\/\/doi.org\/10.1093\/eurheartj\/eht043.","journal-title":"Eur Heart J"},{"issue":"22","key":"2301_CR39","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/archinte.167.22.2417","volume":"167","author":"CM Wu","year":"2007","unstructured":"Wu CM, McLaughlin K, Lorenzetti DL, Hill MD, Manns BJ, Ghali WA. Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med. 2007;167(22):2417\u201322. https:\/\/doi.org\/10.1001\/archinte.167.22.2417.","journal-title":"Arch Intern Med"},{"issue":"9","key":"2301_CR40","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1073\/pnas.81.9.2738","volume":"81","author":"WH Rottmann","year":"1984","unstructured":"Rottmann WH, Tolan DR, Penhoet EE. Complete amino acid sequence for human aldolase B derived from cDNA and genomic clones. Proc Natl Acad Sci USA. 1984;81(9):2738\u201342. https:\/\/doi.org\/10.1073\/pnas.81.9.2738.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"46","key":"2301_CR41","doi-asserted-by":"publisher","first-page":"74526","DOI":"10.18632\/oncotarget.12931","volume":"7","author":"Y Zeng","year":"2016","unstructured":"Zeng Y, Lv Y, Tao L, Ma J, Zhang H, Xu H, et al. G6PC3, ALDOA and CS induction accompanies mir-122 down-regulation in the mechanical asphyxia and can serve as hypoxia biomarkers. Oncotarget. 2016;7(46):74526\u201336. https:\/\/doi.org\/10.18632\/oncotarget.12931.","journal-title":"Oncotarget"},{"issue":"2","key":"2301_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3892\/ijo.2016.3814","volume":"50","author":"K Kawai","year":"2017","unstructured":"Kawai K, Uemura M, Munakata K, Takahashi H, Haraguchi N, Nishimura J, et al. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis. Int J Oncol. 2017;50(2):525\u201334. https:\/\/doi.org\/10.3892\/ijo.2016.3814.","journal-title":"Int J Oncol"},{"issue":"38","key":"2301_CR43","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.1016\/0092-8674(94)90283-6","volume":"269","author":"GL Semenza","year":"1994","unstructured":"Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269(38):23757\u201363. https:\/\/doi.org\/10.1016\/0092-8674(94)90283-6.","journal-title":"J Biol Chem"},{"issue":"14","key":"2301_CR44","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1158\/0008-5472.CAN-16-0401","volume":"76","author":"G Grandjean","year":"2016","unstructured":"Grandjean G, De Jong PR, James BP, Koh MY, Lemos R, Kingston J, et al. Definition of a novel feed-forward mechanism for glycolysis-HIF1\u03b1 signaling in hypoxic tumors highlights aldolase A as a therapeutic target. Cancer Res. 2016;76(14):4259\u201369. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0401.","journal-title":"Cancer Res"},{"key":"2301_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2017.06.001","volume":"403","author":"YC Chang","year":"2017","unstructured":"Chang YC, Chan YC, Chang WM, Lin YF, Yang CJ, Su CY, et al. Feedback regulation of ALDOA activates the HIF-1\u03b1\/MMP9 axis to promote lung cancer progression. Cancer Lett. 2017;403:28\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2017.06.001.","journal-title":"Cancer Lett"},{"issue":"3","key":"2301_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000328","volume":"8","author":"O Yogev","year":"2010","unstructured":"Yogev O, Yogev O, Singer E, Shaulian E, Goldberg M, Fox TD, Pines O. Fumarase: a mitochondrial metabolic enzyme and a cytosolic\/nuclear component of the DNA damage response. PLoS Biol. 2010;8(3): e1000328. https:\/\/doi.org\/10.1371\/journal.pbio.1000328.","journal-title":"PLoS Biol"},{"issue":"4","key":"2301_CR47","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","volume":"150","author":"W Yang","year":"2012","unstructured":"Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, et al. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell. 2012;150(4):685\u201396. https:\/\/doi.org\/10.1016\/j.cell.2012.07.018.","journal-title":"Cell"},{"key":"2301_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fonc.2012.00085","volume":"2","author":"M Yang","year":"2012","unstructured":"Yang M, Soga T, Pollard PJ, Adam J. The emerging role of fumarate as an oncometabolite. Front Oncol. 2012;2:85. https:\/\/doi.org\/10.3389\/fonc.2012.00085.","journal-title":"Front Oncol"},{"issue":"12","key":"2301_CR49","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Gene Dev. 2012;26(12):1326\u201338. https:\/\/doi.org\/10.1101\/gad.191056.112.","journal-title":"Gene Dev"},{"issue":"7","key":"2301_CR50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/ncb3562","volume":"19","author":"T Wang","year":"2017","unstructured":"Wang T, Yu Q, Li J, Hu B, Zhao Q, Ma C, et al. O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency. Nat Cell Biol. 2017;19(7):833\u201343. https:\/\/doi.org\/10.1038\/ncb3562.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2301_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.6133\/apjcn.2008.17.1.02","volume":"17","author":"T Huang","year":"2008","unstructured":"Huang T, Yuan GF, Zhang ZG, Zou ZQ, Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac J Clin Nutr. 2008;17(1):8\u201316. https:\/\/doi.org\/10.6133\/apjcn.2008.17.1.02.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"2","key":"2301_CR52","doi-asserted-by":"publisher","first-page":"H189","DOI":"10.1152\/ajpheart.01218.2011","volume":"303","author":"YR Kim","year":"2012","unstructured":"Kim YR, Kim CS, Naqvi A, Kumar A, Kumar S, Hoffman TA, Irani K. Epigenetic upregulation of p66shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction. Am J Physiol Heart Circ Physiol. 2012;303(2):H189\u201396. https:\/\/doi.org\/10.1152\/ajpheart.01218.2011.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"22","key":"2301_CR53","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1007\/s00018-018-2859-z","volume":"75","author":"T Chen","year":"2018","unstructured":"Chen T, Wu Y, Gu W, Xu Q. Response of vascular mesenchymal stem\/progenitor cells to hyperlipidemia. Cell Mol Life Sci. 2018;75(22):4079\u201391. https:\/\/doi.org\/10.1007\/s00018-018-2859-z.","journal-title":"Cell Mol Life Sci"},{"key":"2301_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154461","volume":"116","author":"EK Valanti","year":"2021","unstructured":"Valanti EK, Dalakoura-Karagkouni K, Siasos G, Kardassis D, Eliopoulos AG, Sanoudou D. Advances in biological therapies for dyslipidemias and atherosclerosis. Metabolism. 2021;116: 154461. https:\/\/doi.org\/10.1016\/j.metabol.2020.154461.","journal-title":"Metabolism"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02301-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:05:15Z","timestamp":1625789115000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02301-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2301"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02301-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-18584\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-18584\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study conformed to the ethical standards of the 1964 Declaration of Helsinki and its later amendments. This study was approved by the Ethics Committee of the Graduate School of Medicine, Chiba University (No. 2012\u2013438, No. 2014\u201344, No. 2016\u201386, No. 2017\u2013251, No. 2018\u2013320, No. 2020\u20131129), including the cooperating Chiba Prefectural Sawara Hospital, Chiba Rosai Hospital, Chiba Aoba Municipal Hospital, and Port Square Kashiwado Clinic. All participating studies, except the JPHC study, obtained written informed consent from all participants according to the protocols approved by their institutional ethical committees. The JPHC study was launched in 1990 before the enactment of ethical guidelines in Japan (2002); thus, obtaining written informed consent for blood sample collection (1990\u20131994) was not mandatory. After being provided with a written or verbal explanation, the participants were asked to provide blood for this study, and their informed consent was obtained in writing or verbally. Their verbal consent was recorded in the list during blood collection. Additionally, in accordance with the ethical guidelines enacted after blood collection, a research summary was published on the homepage, which guarantees the participants the opportunity to refuse participation (\n                      \n                      ). The institutional ethical committees in National Cancer Center approved this study (Approved No. 2003\u2013054).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This work was performed in collaboration with Fujikura Kasei Co., Ltd. Go Tomiyoshi, Rika Nakamura, Natsuko Shinmen, and Hideyuki Kuroda are employees of Fujikura Kasei Co., Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}